Search Results - "Vladareanu, A.‐M."

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 by Béné, M C, Nebe, T, Bettelheim, P, Buldini, B, Bumbea, H, Kern, W, Lacombe, F, Lemez, P, Marinov, I, Matutes, E, Maynadié, M, Oelschlagel, U, Orfao, A, Schabath, R, Solenthaler, M, Tschurtschenthaler, G, Vladareanu, A M, Zini, G, Faure, G C, Porwit, A

“…The European LeukemiaNet (ELN), workpackage 10 (WP10) was designed to deal with diagnosis matters using morphology and immunophenotyping. This group aimed at…”
Get full text

PB2259: MONOCYTE'S INVOLVEMENT IN INFLAMMATORY RESPONSE IN COVID‐19 INFECTION IN CHRONIC RENAL DISEASE by Bumbea, V., Bumbea, H., Ardelean, L., Radulescu, L., Damian, L., Dumitru, I., Lambert, C., Popov, V., Tomuleasa, C., Vladareanu, A.‐M.

Get full text

CML patients in the molecular era - report of five years experience of diagnosis and treatment in a single center by Voican, I, Vladareanu, A M, Bumbea, H, Barsan, L, Vasile, D

“…Chronic myeloid leukemia (CML) represents about 15% of all leukemia cases. Although the incidence of the disease is rather low, the therapeutic progress of the…”
Get full text

Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses by Ciufu, C, Arama, V, Bumbea, H, Dobrea, C, Ion, I, Vladareanu, A M

“…Hepatitis B and C viruses' infections are often associated with hematological disorders in evolution, suggesting that these viruses have a tropism for…”
Get full text

Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms by Vladareanu, A M, Popov, V, Bumbea, H, Onisai, M, Ilea, A, Dobrea, C, Miulescu, M

“…Patients with Myeloproliferative Neoplasms-(MPN) have a high risk of thrombotic complications. Portal vein thrombosis is a severe complication, which in many…”
Get full text

The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections by Bumbea, H, Vladareanu, A M, Vintilescu, A, Radesi, S, Ciufu, C, Onisai, M, Baluta, C, Begu, M, Dobrea, C, Arama, V, Streinu-Cercel, A, Arama, S

“…Chronic lymphoproliferative disorders (CLD) are frequently found in patients with hepatitis viral infections, which can lead to changes in pathogenesis…”
Get full text

3D echocardiography and biomarkers for early diagnosis and prediction of chemotherapy induced right ventricular dysfunction in non-Hodgkin lymphoma patients by Mihalcea, D, Memis, H, Vladareanu, A M, Vinereanu, D

“…Abstract Background RCHOP (rituximab, cyclophosphamide, doxorubicin, oncovin, prednisone) use in non-Hodgkin's lymphoma (NHL) is limited by the risk of…”
Get full text

Chronic lymphocytic leukemia followed by myelodysplastic syndrome and erythroleukemia by Cazaceanu, O, Iova, A, Vladareanu, A M, Onisai, M, Enache, C, Andrus, E

“…CLL patients are more exposed to develop a second neoplasm, but the association. CLL-MDS is an unusual one. We present the case of a 61-year-old male patient,…”
Get full text

3D global longitudinal strain is the best predictor of late cardiotoxicity in non-Hodgkin's lymphoma by Mihalcea, D, Balinisteanu, A, Memis, H, Cosmulescu, G, Vladareanu, A M, Vinereanu, D

“…Abstract   RCHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) in non-Hodgkin's lymphoma (NHL) has a high risk of…”
Get full text

P112 Defects in platelet surface antigens in chronic myeloproliferative syndrome identified by flow cytometry analysis by Bumbea, H, Vladareanu, A.-M, Radesi, S, Vasilache, V, Ciufu, C, Petre, A, Cisleanu, D, Begu, M, Voican, I, Marinescu, C, Popov, V, Onisai, M, Dervesteanu, M

Get full text

P6893D echocardiography, arterial stiffness, and biomarkers for detection and prediction of late cardiotoxicity in non-Hodgkin lymphoma by Mihalcea, D, Memis, H, Balinisteanu, A, Vladareanu, A M, Vinereanu, D

“…Abstract CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) in non-Hodgkin lymphoma (NHL) is limited by risk of cardiotoxicity. Aim. To…”
Get full text

P1582Early detection and prediction of CHOP-induced cardiotoxicity through 3D myocardial deformation, arterial stiffness and cardiac biomarkers in non-Hodgkin lymphoma by Mihalcea, D, Bruja, R, Vladareanu, A M, Andrus, E, Vinereanu, D

Get full text

P1558 Diagnosis and prediction of late cardiotoxicity in non Hodgkin"s lymphoma by 3D echocardiography, vascular ultrasound, and cardiac biomarkers by Mihalcea, D, Balinisteanu, A, Cosmulescu, G, Vladareanu, A M, Vinereanu, D

“…Abstract Funding Acknowledgements Grant PCCDI 83/2018 (BIOVEA) and PN-III-P1-1-TE-2016-0669 CHOP chemotherapy in non-Hodgkin"s lymphoma (NHL) is limited by the…”
Get full text

Myocardial work, combined with arterial stiffness and biomarkers, are able to detect earlier and predict cardiotoxicity in non-Hodgkin lymphoma by Mihalcea, D, Memis, H, Cosmulescu, G, Balinisteanu, A, Vladareanu, AM, Vinereanu, D

“…Abstract Funding Acknowledgements Type of funding sources: None. CHOP (cyclophosphamide, doxorubicin, oncovin, prednisone) in non-Hodgkin lymphoma (NHL) is…”
Get full text

PB2195 ASSESSMENT OF PLATELET MEMBRANE ALTERATION IN PATIENTS WITH MYELOID METAPLASIA WITH MYELOFIBROSIS by Popov, V., Matei, C. O., Matei, B. M., Leu, R., Dumitru, I., Dobrea, C., Trifa, A., Iova, A., Begu, M., Moisescu, M. G., Savopol, T., Kovacs, E., Vladareanu, A. M., Omer, M., Andreescu, M., Patrinoiu, O., Georgescu, D., Bumbea, H.

“…Background: Patients with Myeloid Metaplasia with Myelofibrosis (MMM) present at the onset or during evolution thrombotic complications. In the assessment of…”
Get full text

P068 Acute natural killer cell leukemia a challenge of diagnosis. Case report by Vlădăreanu, A.-M, Bumbea, H, Begu, M, Cîşleanu, D, Ciufu, C, Vasilache, V, Petre, A, Onisâi, M

Get full text

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores by Căzăceanu, O, Vlădăreanu, Am, Bumbea, H, Begu, M, Onisai, M, Enache, C

“…Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders; they are characterized by ineffective hematopoiesis and…”
Get full text

Complex Immunophenotypic Changes as Prognosis Panel in Chronic Lymphocytic Leukemia by Bumbea, Horia, Radesi, Sanziana, Vladareanu, Ana-Maria, Roman, Viviana, Vintilescu, Anamaria

“…The present study proposes to asses the prognosis with consecrated markers CD38 and the new ZAP-70 related to the various patterns of CLL complex…”
Get full text

Rapid Fire Abstract session: new insights in cardiomyopthies434The role of 4D echocardiography and cardiac biomarkers for early detection of chemotherapy induced cardiotoxicity in nonHodgkin lymphoma patients435Identification of proto-oncogenes and genes responsible for myocardial fibrosis and diastolic dysfunction after anticancer treatment under experimental conditions436Wild type transthyretin cardiac amyloidosis: clinical characteristics, echocardiographic findings, and predictors of outcome by Mihalcea, D, Bergler-Klein, J, Grogan, M, Pagourelias, E, Faber, L, Ciampi, Q, Debonnaire, P, Saberniak, J, Florescu, M, Vladareanu, AM, Mihaila, S, Vinereanu, D, Spannbauer, A, Zlabinger, K, Macejovska, D, Maurer, G, Gyongyosi, M, Scott, C, Lin, G, Klarich, K, Miller, W, Dispenzieri, A, Mirea, OC, Duchenne, J, Vovas, G, Van Aelst, L, Claus, P, Van Cleemput, J, Delforge, M, Bogaert, J, Voigt, JU, Burghardt, A, Seggewiss, H, Van Buuren, F, Horstkotte, D, Olivotto, I, Gardini, C, Monserrat, L, Peteiro, J, Lopes, L, Cotrim, C, Losi, MA, Lazzeroni, DE, Picano, E, Joyce, E, Van Den Brink, OVW, Bax, JJ, Delgado, V, Ajmone Marsan, N, Leren, IS, Haland, TF, Hopp, E, Edvardsen, T, Haugaa, KH

Get full text

Is Platelet Aggregation a Useful Investigation in Assessing the Risk of Thrombosis in Patients With JAK-Positive Chronic Myeloproliferative Disorders? Brief Report: A Study on 14 Patients by Popov, V.M., Vladareanu, A.M., Bumbea, H., Casleanu, D., Ilea, A., Onisai, M., Nicolescu, A., Marinescu, C., Ciufu, C., Voican, I., Begu, M., Vintilescu, A.M., Dobrea, C., Kovacs, E., Savopol, T.

“…Patients with chronic myeloproliferative disorders have frequently thrombosis, especially for JAK2-positive patients. The aim of this study is to identify and…”
Get full text